FROM CHILDHOOD SUFFERING TO SCIENTIFIC HOPE: THE STORY OF FIDE MIRÓN

Born in Spain in 1980, Fide Mirón was diagnosed at six months old with congenital erythropoietic porphyria, or Günther disease, an exceptionally rare genetic disorder affecting heme production. This condition caused severe skin blistering, painful wounds, permanent tissue damage, and profound anemia, requiring her father to donate blood every two weeks during her childhood. Growing up with visible physical changes and little medical support, Mirón faced intense isolation, educational interruptions, and the devastating loss of her father in a traffic accident at age nine.

Despite these hardships, Mirón transformed her personal trauma into powerful advocacy. She pursued social work at the University of Alicante and ultimately became president of the Spanish Porphyria Association, as well as taking on leadership roles within FEDER to support individuals living with rare diseases.

Her life took another remarkable turn when she partnered with researcher Óscar Millet at CIC bioGUNE. By sharing her lived experience, Mirón assisted scientists investigating pharmacological chaperoning using the antifungal drug ciclopirox to stabilize the faulty UROS enzyme. This research advanced toward clinical trials after receiving orphan-drug designation in 2022. While Mirón’s own lasting physical scars remain and a definitive cure is not yet guaranteed, her journey stands as a powerful testament to resilience, illustrating how a child left with few answers grew into a woman helping science search for them.